Skip to main content
. 2023 Nov 28;25:49–60. doi: 10.1016/j.reth.2023.11.010

Table 1.

Dosage of plasmid-DNA or siRNA in each CMC-functionalized CaP group.

Dose/defect
group pBMP-7/μg pVEGF/μg siRNA (TNF-α)/μg CaP nanoparticles/mg
CaP/CMC 16.68
CaP/PEI/BMP-7/SiO2 20.0 16.68
CaP/PEI/VEGF/SiO2 20.0 16.68
CaP/PEI/siRNA-TNF-α/SiO2 20.0 16.68
3MixCaP 20.0 20.0 20.0 16.68